• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

e.l.f. Beauty Could See Further Gains in 2021

We're seeing a period of sideways price action before renewed gains.
By BRUCE KAMICH
Sep 23, 2020 | 09:20 AM EDT
Stocks quotes in this article: ELF, WMT, TGT, ULTA

For his second "Executive Decision" segment of Mad Money on Tuesday evening, Jim Cramer spoke with Tarang Amin, chairman and CEO of e.l.f. Beauty (ELF) , the cosmetics maker with shares up 18% thus far in 2020.

Amin said they're very excited to have partnered with Alicia Keys to launch a new lifestyle beauty brand later this year.

Amin was also asked about their strong presence on the social media platform TikTok. He said that e.l.f. is strong with Gen Z consumers.

Despite having a digital-first brand, Amin noted that their partnership with Walmart (WMT) remains strong, as does their sales with their other retail partners like Target (TGT) and Ulta Beauty (ULTA) . Despite the pandemic, e.l.f. is gaining market share.

Let's visit with the charts to see how they're fairing.

In this daily bar chart of ELF, below, we can see that prices made a small but powerful double bottom around $8 in March and early April. Prices took off on the upside and rallied to highs in July and August. Prices have turned sideways the past two to three months and some of the indicators have weakened. The slope of the 50-day moving average line has turned negative but the 200-day moving average line is still positive.

The On-Balance-Volume (OBV) line has weakened a bit since early July which tells us that sellers of ELF have been more aggressive.

The Moving Average Convergence Divergence (MACD) oscillator has been weakening since early June and is now below the zero line in sell territory.

In this weekly bar chart of ELF, below, we see a mixed picture. Prices are in an uptrend above the rising 40-week moving average line and the weekly OBV line is bullish.

The MACD oscillator has crossed to a take profits sell signal and that could mean we see a sideways to lower trend ahead.

In this daily Point and Figure chart of ELF, below, we can see a potential upside price target of $21.50. A new high but not a big target in my opinion.  

In this weekly close only Point and Figure chart of ELF, below, we can see a possible price target in the $42-$43 area.  


Bottom line strategy: In our review of June 1, we said that "ELF looks like it can rally further. Aggressive traders could go long at current levels risking a close below $15. Add to longs above $20 looking for gains to the $33 area longer-term."

Now we see a period of sideways price action before renewed gains. Our targets are $33 and then $43. Risk a close below $16 now.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Personal Products | Retail | Mad Money | Executive Interview

More from Investing

Marveling at the Market's Move? It's All About Momentum

James "Rev Shark" DePorre
Jan 19, 2021 4:41 PM EST

No news can explain the action -- whether the bears believe it or not.

Surface Oncology Is Set for Further Gains - How to Buy It

Bruce Kamich
Jan 19, 2021 3:25 PM EST

Here's our price objective.

My Preference With OneSpan Is Calls So I Can Define My Risk

Timothy Collins
Jan 19, 2021 2:36 PM EST

The last few post-earnings beat downs were greeted with optimism once traders got over the initial disappointment.

A Top Biotechnology Play for 2021

James "Rev Shark" DePorre
Jan 19, 2021 2:07 PM EST

Forte's sole clinic candidate is FB-401 for the treatment of atopic dermatitis, which is the scientific name for eczema.

Boot Barn Gets a Quant Upgrade: Do the Charts Fit?

Bruce Kamich
Jan 19, 2021 1:53 PM EST

Here's our latest analysis and trading strategy for the shares.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:09 AM EST GARY BERMAN

    Is Copper About to Turn to Rust?

    Below is a very long-term copper chart.  As you...
  • 08:02 AM EST GARY BERMAN

    Tuesday Morning Fibocall for for 1/19/2021

    SPX (Long-Term View) The 1/8/21 high @ 3826.69 i...
  • 09:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    When it's time to sell, will you act or freeze?
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login